Cimpress
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 months.
- Recent price momentum is -29.0% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 8.6% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 15.9x | Better than 55% |
| Forward P/E | 11.8x | Better than 69% |
| Price / Sales | 0.4x | Better than 94% |
| P/E vs own 5-yr range | 65th pctl | Better than 45% |
Growth A-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 6.7% | Better than 53% |
| Net income CAGR (3Y) | 20.5% | Better than 73% |
| Free cash flow CAGR (3Y) | 83.9% | Better than 91% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 46.3% | Better than 58% |
| Operating margin | 6.9% | Better than 41% |
| Net margin | 2.6% | Better than 35% |
| Return on equity | 84.3% | Better than 97% |
| Return on invested capital | 11.9% | Better than 75% |
Momentum D+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -38.6% | Better than 11% |
| 6-month return | -47.4% | Better than 8% |
| 12-month return (ex latest month) | 21.6% | Better than 60% |
| Distance below 52-week high | 49.5% | Better than 19% |
Financial Health D
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 0.7x | Better than 8% |
| Debt to assets | 81.2% | Better than 3% |
| Interest coverage | 2.4x | Better than 40% |
| Free cash flow / net income | 121.4% | Better than 52% |
Analyst View N/A
What the Street thinks: share of Buy ratings and upside to the average target.
Not enough data to grade this factor.
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 54.24
- Open
- 53.58
- Day range
- 53.51 - 55.77
- Avg price
- 54.10
- Volume
- 560.81K
- Turnover
- 30.34M
- Turnover ratei
- 3.77%
- Volume ratioi
- 1.16
- Amplitudei
- 4.17%
- 52-week rangei
- 52.72 - 106.58
Valuation
- P/Ei
- 14.20
- P/E (TTM)i
- 15.92
- P/Bi
- -2.65
- EPSi
- 3.79
- Book value / shi
- -20.28
- Net profit
- 93.31M
- Net assets
- -499.24M
Share structure
- Market cap
- 1.32B
- Float capi
- 801.38M
- Shares out
- 24.62M
- Float sharesi
- 14.89M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
49.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+1.19M net over the window
Short interest
- Shares short
- 2.11M
- % of floati
- 8.58%
- Days to coveri
- 7.39
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Cimpress (CMPR)?
Cimpress last traded at 53.81. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Cimpress's market cap?
About 1.32B.
What is the P/E ratio of Cimpress?
The trailing twelve-month P/E is 15.92, above its own 5-year average of 15.91 — in the middle of its historical range (64.51% percentile). See the Valuation tab for the full history.
Does Cimpress pay a dividend?
Cimpress does not currently pay a regular dividend.
Is Cimpress a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 96.00, which implies 78.4% upside from the current price. This is not investment advice.
What is Cimpress's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Cimpress a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Cimpress discussion 0 comments